Advertisement

Clinical Journal of Gastroenterology

, Volume 11, Issue 3, pp 188–192 | Cite as

Successful endoscopic sphincterotomy for choledocholithiasis in a patient with severe hemophilia A and inhibitors

  • Ryo Sugiura
  • Masaki Kuwatani
  • Kazumichi Kawakubo
  • Itsuki Sano
  • Shin Kato
  • Tomoyuki Endo
  • Naoya Sakamoto
Case Report
  • 122 Downloads

Abstract

Endoscopic sphincterotomy (ES) is a standard procedure for bile duct stone removal. However, the safety of ES in patients with hemophilia remains unknown. We treated a 46-year-old man who had choledocholithiasis and severe hemophilia A with high-responding inhibitors during immune tolerance induction therapy. Since coagulation factor VIII inhibitors neutralize and inactivate endogenous and exogenous factor VIII, bleeding risk is higher in hemophilia A patients with inhibitors than in those without inhibitors. With adequate pre- and post-procedure monitoring of the clotting factor and supplemented clotting factor, the patient could safely undergo ES without bleeding complications. ES can be also an effective and safe first-line therapy for choledocholithiasis in patients with hemophilia and inhibitors under the condition of appropriate management.

Keywords

Endoscopic sphincterotomy Hemophilia Choledocholithiasis 

Notes

Compliance with ethical standards

Conflict of interest

Drs. Sugiura, Kuwatani, Kawakubo, Sano, Kato, Endo and Sakamoto declare that they have no conflict of interest.

Human/animal rights

All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

Informed consent

Informed consent was obtained from the patient for being included in the study.

References

  1. 1.
    Aliperti G. Complications related to diagnostic and therapeutic endoscopic retrograde cholangiopancreatography. Gastrointest Endosc Clin N Am. 1996;6(2):379–407 Epub 1996/04/01.PubMedCrossRefGoogle Scholar
  2. 2.
    Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37(3):383–93 Epub 1991/05/01.CrossRefPubMedGoogle Scholar
  3. 3.
    Katsinelos P, Pilpilidis I, Paroutoglou G, et al. Endoscopic sphincterotomy in adult hemophiliac patients with choledocholithiasis. Gastrointest Endosc. 2003;58(5):788–91 Epub 2003/11/05.CrossRefPubMedGoogle Scholar
  4. 4.
    Fujita N, Maguchi H, Komatsu Y, et al. Endoscopic sphincterotomy and endoscopic papillary balloon dilatation for bile duct stones: a prospective randomized controlled multicenter trial. Gastrointest Endosc. 2003;57(2):151–5 Epub 2003/01/31.CrossRefPubMedGoogle Scholar
  5. 5.
    Disario JA, Freeman ML, Bjorkman DJ, et al. Endoscopic balloon dilation compared with sphincterotomy for extraction of bile duct stones. Gastroenterology. 2004;127(5):1291–9 Epub 2004/11/03.CrossRefPubMedGoogle Scholar
  6. 6.
    Watanabe H, Yoneda M, Tominaga K, et al. Comparison between endoscopic papillary balloon dilatation and endoscopic sphincterotomy for the treatment of common bile duct stones. J Gastroenterol. 2007;42(1):56–62 Epub 2007/02/27.CrossRefPubMedGoogle Scholar
  7. 7.
    Sakai M, Taki M, Ieko M, et al. Hemostatic treatment guidelines forinhibitorspossess congenital hemophilia patients. Jpn J Thromb Hemost. 2013;24(6):640–58.CrossRefGoogle Scholar
  8. 8.
    Kasper CK. Diagnosis and management of inhibitors to factor VIII and IX. World Fed Hemoph. 2004;1:22Google Scholar
  9. 9.
    Tiede A. Half-life extended factor VIII for the treatment of hemophilia A. J Thromb Haemost. 2015;13(Suppl 1):S176–9 Epub 2015/07/08.CrossRefPubMedGoogle Scholar
  10. 10.
    Katsinelos P, Kountouras J, Chatzimavroudis G, et al. A novel technique of injection treatment for endoscopic sphincterotomy-induced hemorrhage. Endoscopy. 2007;39(7):631–6 Epub 2007/07/06.CrossRefPubMedGoogle Scholar
  11. 11.
    Eisen GM, Baron TH, Dominitz JA, et al. Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures. Gastrointest Endosc. 2002;55(7):775–9 Epub 2002/05/25.CrossRefPubMedGoogle Scholar
  12. 12.
    Van Os EC, Kamath PS, Gostout CJ, et al. Gastroenterological procedures among patients with disorders of hemostasis: evaluation and management recommendations. Gastrointest Endosc. 1999;50(4):536–43 Epub 1999/09/29.CrossRefPubMedGoogle Scholar
  13. 13.
    Scharrer I, Bray GL, Neutzling O. Incidence of inhibitors in haemophilia A patients–a review of recent studies of recombinant and plasma-derived factor VIII concentrates. Haemophilia Off J World Fed Hemophilia. 1999;5(3):145–54 Epub 1999/08/12.CrossRefGoogle Scholar
  14. 14.
    Dimichele D. Immune tolerance therapy for factor VIII inhibitors: moving from empiricism to an evidence-based approach. J Thromb Haemost. 2007;5(Suppl 1):143–50 Epub 2007/08/01.CrossRefPubMedGoogle Scholar
  15. 15.
    White GC, Rosendaal F, Aledort LM, et al. Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost. 2002;85(3):560 (Epub 2001/04/20).Google Scholar
  16. 16.
    Acharya SS, DiMichele DM. Management of factor VIII inhibitors. Best Pract Res Clin Haematol. 2006;19(1):51–66 Epub 2005/12/27.CrossRefPubMedGoogle Scholar
  17. 17.
    Kawabe T, Komatsu Y, Tada M, et al. Endoscopic papillary balloon dilation in cirrhotic patients: removal of common bile duct stones without sphincterotomy. Endoscopy. 1996;28(8):694–8 Epub 1996/10/01.CrossRefPubMedGoogle Scholar
  18. 18.
    Sasahira N, Tada M, Yoshida H, et al. Extrahepatic biliary obstruction after percutaneous tumour ablation for hepatocellular carcinoma: aetiology and successful treatment with endoscopic papillary balloon dilatation. Gut. 2005;54(5):698–702 Epub 2005/04/16.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Takahara N, Isayama H, Sasaki T, et al. Endoscopic papillary balloon dilation for bile duct stones in patients on hemodialysis. J Gastroenterol. 2012;47(8):918–23 Epub 2012/02/23.CrossRefPubMedGoogle Scholar

Copyright information

© Japanese Society of Gastroenterology 2018

Authors and Affiliations

  1. 1.Department of Gastroenterology and HepatologyHokkaido University Faculty of Medicine and Graduate School of MedicineSapporoJapan
  2. 2.Division of EndoscopyHokkaido University HospitalSapporoJapan
  3. 3.Department of HematologyHokkaido University Graduate School of MedicineSapporoJapan

Personalised recommendations